Tower Research Capital LLC (Trc) Anixa Biosciences Inc Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 1,799 shares of ANIX stock, worth $5,109. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,799
Previous 1,483
21.31%
Holding current value
$5,109
Previous $4,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding ANIX
# of Institutions
62Shares Held
5.73MCall Options Held
7.1KPut Options Held
26.7K-
Vanguard Group Inc Valley Forge, PA1.39MShares$3.96 Million0.0% of portfolio
-
D.A. Davidson & Co.671KShares$1.91 Million0.01% of portfolio
-
Laird Norton Trust Company, LLC622KShares$1.77 Million0.21% of portfolio
-
Ubs Group Ag534KShares$1.52 Million0.0% of portfolio
-
Mission Wealth Management, LP470KShares$1.33 Million0.03% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $87.1M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...